Jpmorgan Chase & CO Abbott Laboratories Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Jpmorgan Chase & CO holds 39,923,837 shares of ABT stock, worth $5.16 Billion. This represents 0.42% of its overall portfolio holdings.

Number of Shares

39,923,837

Previous 35,180,518 13.48%

Holding current value

$5.16 Billion

Previous $3.98 Billion 33.09%

% of portfolio

0.42%

Previous 0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$111.1 - $140.22 $527 Million - $665 Million	4,743,319 Added 13.48%	39,923,837 $5.3 Billion
Q4 2024 Feb 12, 2025	BUY	$111.93 - $119.39 $701 Million - $748 Million	6,262,503 Added 21.66%	35,180,518 $3.98 Billion
Q3 2024 Dec 26, 2024	BUY	$100.07 - $118.13 $1.42 Billion - $1.67 Billion	14,142,281 Added 95.71%	28,918,015 $3.3 Billion
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $1.42 Billion - $1.67 Billion	14,142,281 Added 95.71%	28,918,015 $3.3 Billion
Q2 2024 Dec 26, 2024	SELL	$100.73 - $112.44 $1.42 Billion - $1.59 Billion	-14,142,281 Reduced 48.9%	14,775,734 $1.54 Billion
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $67.6 Million - $75.5 Million	671,397 Added 4.76%	14,775,734 $1.54 Billion
Q1 2024 Dec 26, 2024	SELL	$109.52 - $120.96 $1.62 Billion - $1.79 Billion	-14,813,678 Reduced 51.23%	14,104,337 $1.6 Billion
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $90.5 Million - $100 Million	826,742 Added 6.23%	14,104,337 $1.6 Billion
Q4 2023 Dec 26, 2024	SELL	$90.19 - $110.4 $1.41 Billion - $1.73 Billion	-15,640,420 Reduced 54.09%	13,277,595 $1.46 Billion
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $312 Million - $382 Million	-3,457,426 Reduced 20.66%	13,277,595 $1.46 Billion
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $168 Million - $202 Million	1,760,322 Added 11.76%	16,735,021 $1.62 Billion
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $81.8 Million - $91.1 Million	811,446 Added 5.73%	14,974,699 $1.63 Billion
Q1 2023 May 18, 2023	BUY	$96.86 - $114.01 $79.5 Million - $93.6 Million	820,608 Added 6.15%	14,163,253 $1.43 Billion
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $28.7 Million - $33.8 Million	296,765 Added 2.27%	13,342,645 $1.35 Billion
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $11 Million - $12.9 Million	-115,755 Reduced 0.88%	13,045,880 $1.43 Billion
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $10.4 Million - $12 Million	107,069 Added 0.82%	13,161,635 $1.27 Billion
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $18.4 Million - $22.2 Million	-180,327 Reduced 1.36%	13,054,566 $1.42 Billion
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $447 Million - $546 Million	3,923,436 Added 42.14%	13,234,893 $1.57 Billion
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $84.2 Million - $103 Million	728,925 Added 8.49%	9,311,457 $1.31 Billion
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $1 Billion - $1.11 Billion	8,582,532 New	8,582,532 $1.01 Billion

Others Institutions Holding ABT

# of Institutions

3,595

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $227B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Abbott Laboratories Transaction History